A driver never works alone—interplay networks of mutant p53, MYC, RAS, and other universal oncogenic drivers in human cancer

13Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

The knowledge accumulating on the occurrence and mechanisms of the activation of oncogenes in human neoplasia necessitates an increasingly detailed understanding of their systemic interactions. None of the known oncogenic drivers work in isolation from the other oncogenic pathways. The cooperation between these pathways is an indispensable element of a multistep carcinogenesis, which apart from inactivation of tumor suppressors, always includes the activation of two or more proto-oncogenes. In this review we focus on representative examples of the interaction of major oncogenic drivers with one another. The drivers are selected according to the following criteria: (1) the highest frequency of known activation in human neoplasia (by mutations or otherwise), (2) activation in a wide range of neoplasia types (universality) and (3) as a part of a distinguishable pathway, (4) being a known cause of phenotypic addiction of neoplastic cells and thus a promising therapeutic target. Each of these universal oncogenic factors—mutant p53, KRAS and CMYC proteins, telomerase ribonucleoprotein, proteasome machinery, HSP molecular chaperones, NF-κB and WNT pathways, AP-1 and YAP/TAZ transcription factors and non-coding RNAs—has a vast network of molecular interrelations and common partners. Understanding this network allows for the hunt for novel therapeutic targets and protocols to counteract drug resistance in a clinical neoplasia treatment.

References Powered by Scopus

Mutational landscape and significance across 12 major cancer types

3490Citations
N/AReaders
Get full text

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

2461Citations
N/AReaders
Get full text

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

2157Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The Gain-of-Function p53 R248W Mutant Promotes Migration by STAT3 Deregulation in Human Pancreatic Cancer Cells

32Citations
N/AReaders
Get full text

Molecular Targeting of the Most Functionally Complex Gene in Precision Oncology: p53

7Citations
N/AReaders
Get full text

Autophagy flux correlates with upregulation of AKT-1 in RAS mutated colon cancer cells

6Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Grzes, M., Oron, M., Staszczak, Z., Jaiswar, A., Nowak-Niezgoda, M., & Walerych, D. (2020, June 1). A driver never works alone—interplay networks of mutant p53, MYC, RAS, and other universal oncogenic drivers in human cancer. Cancers. MDPI AG. https://doi.org/10.3390/cancers12061532

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 11

48%

Researcher 9

39%

Professor / Associate Prof. 2

9%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 13

48%

Medicine and Dentistry 8

30%

Pharmacology, Toxicology and Pharmaceut... 4

15%

Agricultural and Biological Sciences 2

7%

Save time finding and organizing research with Mendeley

Sign up for free